Chien-ching H. Hung

Chien-ching H. Hung

Hsinchu, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 288 publications

Phase 3 Trial of Weekly Oral Islatravir-Lenacapavir for HIV-1 Treatment.

Phase 3 Trial of Weekly Oral Islatravir-Lenacapavir for HIV-1 Treatment.

Journal: The New England journal of medicine

Published: July 29, 2026

Comparative Effectiveness of Three Benzathine Penicillin G-Based Regimens in People with HIV Who Presented with Early Syphilis.

Comparative Effectiveness of Three Benzathine Penicillin G-Based Regimens in People with HIV Who Presented with Early Syphilis.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: June 18, 2026

Dual susceptibility to hepatitis A and B among people newly diagnosed with HIV in Taiwan during the vaccination era: a multicenter study.

Dual susceptibility to hepatitis A and B among people newly diagnosed with HIV in Taiwan during the vaccination era: a multicenter study.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: June 05, 2026

Single-dose Ceftriaxone Plus 7-Day Doxycycline Versus Single-dose Benzathine Penicillin G Plus 7-Day Doxycycline in the Treatment of Early Syphilis in People With HIV: a Pilot Randomized Noninferiority Trial.

Single-dose Ceftriaxone Plus 7-Day Doxycycline Versus Single-dose Benzathine Penicillin G Plus 7-Day Doxycycline in the Treatment of Early Syphilis in People With HIV: a Pilot Randomized Noninferiority Trial.

Journal: Open forum infectious diseases

Published: May 28, 2026

Two-year durability of MVA-BN vaccine-induced antibodies and the risk of Mpox breakthrough infections among high-risk populations: a prospective, longitudinal study.

Two-year durability of MVA-BN vaccine-induced antibodies and the risk of Mpox breakthrough infections among high-risk populations: a prospective, longitudinal study.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: May 04, 2026

Impact of doxycycline post-exposure prophylaxis on the prevalence of resistance-associated mutations of Mycoplasma genitalium among high-risk people.

Impact of doxycycline post-exposure prophylaxis on the prevalence of resistance-associated mutations of Mycoplasma genitalium among high-risk people.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: April 25, 2026

Birth in the neonatal HBV vaccination era and hepatitis B surface antigen seroclearance in people with HIV and HBV coinfection on tenofovir-containing antiretroviral therapy.

Birth in the neonatal HBV vaccination era and hepatitis B surface antigen seroclearance in people with HIV and HBV coinfection on tenofovir-containing antiretroviral therapy.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: April 13, 2026

Safety and efficacy of switching to bictegravir-lenacapavir versus continuing bictegravir-emtricitabine-tenofovir alafenamide in virologically suppressed people with HIV-1 (ARTISTRY-2): a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial.

Safety and efficacy of switching to bictegravir-lenacapavir versus continuing bictegravir-emtricitabine-tenofovir alafenamide in virologically suppressed people with HIV-1 (ARTISTRY-2): a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial.

Journal: The lancet. HIV

Published: March 17, 2026

Rapid progressive PML-IRIS presenting as multifocal infarcts and uncal herniation in a newly diagnosed person with HIV - case report and literature review.

Rapid progressive PML-IRIS presenting as multifocal infarcts and uncal herniation in a newly diagnosed person with HIV - case report and literature review.

Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi

Published: March 13, 2026

B/F/TAF in people with both HIV-1 and hepatitis B: outcomes from the ALLIANCE open-label extension phase.

B/F/TAF in people with both HIV-1 and hepatitis B: outcomes from the ALLIANCE open-label extension phase.

Journal: AIDS research and therapy

Published: February 11, 2026

Trends of bacterial sexually transmitted infections with doxycycline post-exposure prophylaxis among people using pre-exposure prophylaxis for HIV.

Trends of bacterial sexually transmitted infections with doxycycline post-exposure prophylaxis among people using pre-exposure prophylaxis for HIV.

Journal: Sexually transmitted infections

Published: January 28, 2026

Dynamics of anal HPV infection after 9vHPV vaccination in men who have sex with men (MSM) with HIV: A prospective, controlled cohort study.

Dynamics of anal HPV infection after 9vHPV vaccination in men who have sex with men (MSM) with HIV: A prospective, controlled cohort study.

Journal: Human vaccines & immunotherapeutics

Published: January 26, 2026

Showing 1-12 of 288

Last Updated: 09/26/2026